Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1845 1
1880 1
1884 1
1885 1
1886 3
1890 2
1894 1
1896 1
1903 1
1914 1
1944 1
1945 3
1946 7
1947 7
1948 6
1949 3
1950 3
1951 7
1952 3
1953 1
1954 5
1955 6
1956 4
1957 4
1958 2
1959 8
1960 4
1961 1
1962 7
1963 6
1964 11
1965 8
1966 4
1967 7
1968 10
1969 11
1970 5
1971 5
1972 14
1973 9
1974 6
1975 5
1976 15
1977 12
1978 16
1979 14
1980 10
1981 24
1982 13
1983 18
1984 9
1985 12
1986 17
1987 13
1988 18
1989 20
1990 20
1991 21
1992 24
1993 21
1994 29
1995 29
1996 28
1997 30
1998 27
1999 29
2000 38
2001 45
2002 39
2003 54
2004 60
2005 65
2006 62
2007 70
2008 91
2009 82
2010 114
2011 124
2012 114
2013 108
2014 131
2015 124
2016 151
2017 141
2018 165
2019 134
2020 201
2021 242
2022 185
2023 170
2024 83

Text availability

Article attribute

Article type

Publication date

Search Results

3,144 results

Results by year

Filters applied: . Clear all
Page 1
Single-cell eQTL mapping identifies cell type-specific genetic control of autoimmune disease.
Yazar S, Alquicira-Hernandez J, Wing K, Senabouth A, Gordon MG, Andersen S, Lu Q, Rowson A, Taylor TRP, Clarke L, Maccora K, Chen C, Cook AL, Ye CJ, Fairfax KA, Hewitt AW, Powell JE. Yazar S, et al. Among authors: cook al. Science. 2022 Apr 8;376(6589):eabf3041. doi: 10.1126/science.abf3041. Epub 2022 Apr 8. Science. 2022. PMID: 35389779
Estimated Prevalence and Clinical Manifestations of UBA1 Variants Associated With VEXAS Syndrome in a Clinical Population.
Beck DB, Bodian DL, Shah V, Mirshahi UL, Kim J, Ding Y, Magaziner SJ, Strande NT, Cantor A, Haley JS, Cook A, Hill W, Schwartz AL, Grayson PC, Ferrada MA, Kastner DL, Carey DJ, Stewart DR. Beck DB, et al. Among authors: cook a. JAMA. 2023 Jan 24;329(4):318-324. doi: 10.1001/jama.2022.24836. JAMA. 2023. PMID: 36692560 Free PMC article.
Abiraterone acetate and prednisolone with or without enzalutamide for high-risk non-metastatic prostate cancer: a meta-analysis of primary results from two randomised controlled phase 3 trials of the STAMPEDE platform protocol.
Attard G, Murphy L, Clarke NW, Cross W, Jones RJ, Parker CC, Gillessen S, Cook A, Brawley C, Amos CL, Atako N, Pugh C, Buckner M, Chowdhury S, Malik Z, Russell JM, Gilson C, Rush H, Bowen J, Lydon A, Pedley I, O'Sullivan JM, Birtle A, Gale J, Srihari N, Thomas C, Tanguay J, Wagstaff J, Das P, Gray E, Alzoueb M, Parikh O, Robinson A, Syndikus I, Wylie J, Zarkar A, Thalmann G, de Bono JS, Dearnaley DP, Mason MD, Gilbert D, Langley RE, Millman R, Matheson D, Sydes MR, Brown LC, Parmar MKB, James ND; Systemic Therapy in Advancing or Metastatic Prostate cancer: Evaluation of Drug Efficacy (STAMPEDE) investigators. Attard G, et al. Among authors: cook a. Lancet. 2022 Jan 29;399(10323):447-460. doi: 10.1016/S0140-6736(21)02437-5. Epub 2021 Dec 23. Lancet. 2022. PMID: 34953525 Free PMC article.
SHP2 Inhibition Sensitizes Diverse Oncogene-Addicted Solid Tumors to Re-treatment with Targeted Therapy.
Drilon A, Sharma MR, Johnson ML, Yap TA, Gadgeel S, Nepert D, Feng G, Reddy MB, Harney AS, Elsayed M, Cook AW, Wong CE, Hinklin RJ, Jiang Y, Brown EN, Neitzel NA, Laird ER, Wu WI, Singh A, Wei P, Ching KA, Gaudino JJ, Lee PA, Hartley DP, Rothenberg SM. Drilon A, et al. Among authors: cook aw. Cancer Discov. 2023 Aug 4;13(8):1789-1801. doi: 10.1158/2159-8290.CD-23-0361. Cancer Discov. 2023. PMID: 37269335 Free PMC article.
Spatially coordinated heterochromatinization of long synaptic genes in fragile X syndrome.
Malachowski T, Chandradoss KR, Boya R, Zhou L, Cook AL, Su C, Pham K, Haws SA, Kim JH, Ryu HS, Ge C, Luppino JM, Nguyen SC, Titus KR, Gong W, Wallace O, Joyce EF, Wu H, Rojas LA, Phillips-Cremins JE. Malachowski T, et al. Among authors: cook al. Cell. 2023 Dec 21;186(26):5840-5858.e36. doi: 10.1016/j.cell.2023.11.019. Cell. 2023. PMID: 38134876 Free article.
Schistosomiasis in the United States.
Cook AK. Cook AK. Vet Clin North Am Small Anim Pract. 2022 Nov;52(6):1283-1303. doi: 10.1016/j.cvsm.2022.06.009. Vet Clin North Am Small Anim Pract. 2022. PMID: 36336421 Review.
High-throughput hit-squad tackles trypanosomes.
Cook AD, Higgins MK. Cook AD, et al. Trends Parasitol. 2021 Sep;37(9):772-774. doi: 10.1016/j.pt.2021.07.005. Epub 2021 Jul 24. Trends Parasitol. 2021. PMID: 34315657 Review.
Dysphagia-optimised intensity-modulated radiotherapy versus standard intensity-modulated radiotherapy in patients with head and neck cancer (DARS): a phase 3, multicentre, randomised, controlled trial.
Nutting C, Finneran L, Roe J, Sydenham MA, Beasley M, Bhide S, Boon C, Cook A, De Winton E, Emson M, Foran B, Frogley R, Petkar I, Pettit L, Rooney K, Roques T, Srinivasan D, Tyler J, Hall E; DARS Trialist Group. Nutting C, et al. Among authors: cook a. Lancet Oncol. 2023 Aug;24(8):868-880. doi: 10.1016/S1470-2045(23)00265-6. Epub 2023 Jul 6. Lancet Oncol. 2023. PMID: 37423227 Free article. Clinical Trial.
Toward a standard model for autophagosome biogenesis.
Cook ASI, Hurley JH. Cook ASI, et al. J Cell Biol. 2023 Jul 3;222(7):e202304011. doi: 10.1083/jcb.202304011. Epub 2023 Jun 5. J Cell Biol. 2023. PMID: 37273223 Free PMC article.
3,144 results